We are focusing on the removal of impurities such as ammonia and other contaminants! There is also a quality assurance period.
"Secretome Extract" is a cosmetic ingredient that has been purified, concentrated, and standardized from human adipose-derived stem cell secretome. We focus on the removal of impurities such as ammonia and other contaminants. We offer a new liposome-encapsulated product, "Secretome Extract Nano," as well as a concentrated type called "ISOL." 【Secretome Extract Nano Specifications】 ■ Specifications: 100mL (5,000 TBU), 2mL (100 TBU) ■ Quality Assurance Period: 1 year after production ■ Classification: Cosmetic Ingredient *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【ISOL Specifications】 ■Specifications: 100mL (5,000 TBU), 2mL (100 TBU) ■Product Codes: CLB100A, CLE2A ■Quality Assurance Period: 3 years after manufacture ■Classification: Cosmetic Ingredients *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
This is a venture company established based on the stem cell research of Hirotaro Yoshimura, representing the Jichi Medical University. Through research and development of stem cells and secretome (a collective term for the factors secreted by stem cells), we are engaged in the cosmetics raw materials business, stem cell regenerative medicine business, and pharmaceutical development business. Since our founding, we have been conducting joint research with Jichi Medical University, providing evidence-based products. Starting in April 2024, we will establish a joint research course called "Department of Regenerative Medical Science," deepening our collaboration with the university. We are actively promoting joint research with academia and companies. If you are interested in joint research with us, please feel free to contact us. April 2024: We obtained a license for the manufacture and sale of first-class pharmaceuticals. License number: 13A1X10160 Date of issuance: April 12, 2024 With the acquisition of the pharmaceutical manufacturing and sales license, we are strengthening our production system by establishing a proper manufacturing management and quality control system through compliance and thorough adherence to GQP/GMP.
